{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T12:36:30Z","timestamp":1784810190500,"version":"3.55.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.bcmd.2025.102909","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T02:05:55Z","timestamp":1737079555000},"page":"102909","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Red blood cell pyruvate kinase properties in Townes and Berkeley sickle cell disease mouse models \u2013 Of mice and men"],"prefix":"10.1016","volume":"111","author":[{"given":"Marissa J.M.","family":"Traets","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Titine J.J.","family":"Ruiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita W.","family":"Rijneveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith J.","family":"Jans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Alt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minke A.E.","family":"Rab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"van Wijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte A.","family":"van Oirschot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2025.102909_bb0005","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJMra1510865","article-title":"Sickle cell disease","volume":"376","author":"Piel","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2025.102909_bb0010","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1126\/science.278.5339.873","article-title":"Knockout-transgenic mouse model of sickle cell disease","volume":"278","author":"Ryan","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.bcmd.2025.102909_bb0015","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.278.5339.876","article-title":"Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease","volume":"278","author":"P\u00e1szty","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.bcmd.2025.102909_bb0020","series-title":"Correction of Sickle Cell Disease by Homologous Recombination in Embryonic Stem Cells","author":"Wu","year":"2006"},{"key":"10.1016\/j.bcmd.2025.102909_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcmd.2022.102660","article-title":"Mitapivat increases ATP and decreases oxidative stress and erythrocyte mitochondria retention in a SCD mouse model","volume":"95","author":"Quezado","year":"2022","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2025.102909_bb0030","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1182\/bloodadvances.2020003604","article-title":"FT-4202, an oral PKR activator, has potent antisickling effects and improves RBC survival and Hb levels in SCA mice","volume":"5","author":"Shrestha","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.bcmd.2025.102909_bb0035","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.27082","article-title":"Effects of 2,3-DPG knockout on SCD phenotype in Townes SCD model mice","author":"Barakat","year":"2023","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2025.102909_bb0040","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/bjh.18771","article-title":"GBT021601 improves red blood cell health and the pathophysiology of sickle cell disease in a murine model","volume":"202","author":"Dufu","year":"2023","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2025.102909_bb0045","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/bjh.14214","article-title":"GBT440 increases haemoglobin oxygen affinity, reduces sickling and prolongs RBC half-life in a murine model of sickle cell disease","volume":"175","author":"Oksenberg","year":"2016","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2025.102909_bb0050","doi-asserted-by":"crossref","first-page":"H400","DOI":"10.1152\/ajpheart.00048.2021","article-title":"Increased hemoglobin affinity for oxygen with GBT1118 improves hypoxia tolerance in sickle cell mice","volume":"321","author":"Dufu","year":"2021","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bcmd.2025.102909_bb0055","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1182\/bloodadvances.2022007809","article-title":"Improvement of hemolytic anemia with GBT1118 is renoprotective in transgenic sickle mice","volume":"6","author":"Ren","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.bcmd.2025.102909_bb0060","article-title":"Mouse models of sickle cell disease: imperfect and yet very informative","author":"Kamimura","year":"2023","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2025.102909_bb0065","article-title":"Limitations of mouse models for sickle cell disease conferred by their human globin transgene configurations","volume":"15","author":"Woodard","year":"2022","journal-title":"DMM Disease Models and Mechanisms"},{"key":"10.1016\/j.bcmd.2025.102909_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2023.101103","article-title":"Activation of pyruvate kinase as therapeutic option for rare hemolytic anemias: shedding new light on an old enzyme","volume":"61","author":"van Dijk","year":"2023","journal-title":"Blood Rev."},{"key":"10.1016\/j.bcmd.2025.102909_bb0075","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1182\/blood.2020008635","volume":"137","author":"Rab","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2025.102909_bb0080","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1046\/j.1365-2141.2003.04781.x","article-title":"Reactive oxygen species and phosphatidylserine externalization in murine sickle red cells","volume":"124","author":"Banerjee","year":"2004","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2025.102909_bb0085","doi-asserted-by":"crossref","first-page":"E226","DOI":"10.1002\/ajh.26554","article-title":"Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in sickle cell disease: a phase 2, open-label study","volume":"97","author":"van Dijk","year":"2022","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2025.102909_bb0090","author":"Xu"},{"key":"10.1016\/j.bcmd.2025.102909_bb0095","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/cpdd.1058","article-title":"Safety, pharmacokinetics, and pharmacodynamics of etavopivat (FT-4202), an allosteric activator of pyruvate kinase-R, in healthy adults: a randomized, placebo-controlled, double-blind, first-in-human phase 1 trial","volume":"11","author":"Forsyth","year":"2022","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.bcmd.2025.102909_bb0100","first-page":"35","article-title":"International Committee for Standardization in Haematology: recommended methods for red-cell enzyme analysis","volume":"33","author":"Beutler","year":"1977","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2025.102909_bb0105","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/ajh.25325","article-title":"Addressing the diagnostic gaps in pyruvate kinase deficiency: consensus recommendations on the diagnosis of pyruvate kinase deficiency","volume":"94","author":"Bianchi","year":"2019","journal-title":"Am. J. Hematol."},{"issue":"3","key":"10.1016\/j.bcmd.2025.102909_bb0110","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0009-8981(73)90487-7","article-title":"Additional diagnostic procedures for the detection of abnormal red cell pyruvate kinase","volume":"43","author":"Blume","year":"1973","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bcmd.2025.102909_bb0115","first-page":"882","article-title":"Improved method for the determination of blood glutathione","volume":"61","author":"Beutler","year":"1963","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.bcmd.2025.102909_bb0120","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jchromb.2017.07.010","article-title":"A fit-for-purpose LC\u2013MS\/MS method for the simultaneous quantitation of ATP and 2,3-DPG in human K2EDTA whole blood","volume":"1061\u20131062","author":"Kim","year":"2017","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.bcmd.2025.102909_bb0125","series-title":"Separation of Pentose Phosphate Pathway, Glycolysis, and Energy Metabolites Using an ACQUITY Premier System With an Atlantis Premier BEH Z-HILIC Column","author":"Smith","year":"2021"},{"key":"10.1016\/j.bcmd.2025.102909_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcmd.2023.102800","article-title":"Calcium flux alterations in erythrocytes from sickle cell mice: the relevance of mean corpuscular volume","volume":"104","author":"Almeida","year":"2024","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2025.102909_bb0135","article-title":"Characterization of sickling during controlled automated deoxygenation with oxygen gradient ektacytometry","volume":"2019","author":"Rab","year":"2019","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.bcmd.2025.102909_bb0140","unstructured":"C.E.B.G. Guarnone R, Performance characteristics of Hemox-Analyzer for assessment of the hemoglobin dissociation curve, Haematologica 80 (1995) 426\u2013430."},{"key":"10.1016\/j.bcmd.2025.102909_bb0145","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/ajh.25443","article-title":"Rapid and reproducible characterization of sickling during automated deoxygenation in sickle cell disease patients","volume":"94","author":"Rab","year":"2019","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2025.102909_bb0150","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/ajh.26923","article-title":"In vivo evaluation of the effect of sickle cell hemoglobin S, C and therapeutic transfusion on erythrocyte metabolism and cardiorenal dysfunction","volume":"98","author":"D\u2019Alessandro","year":"2023","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2025.102909_bb0155","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1182\/blood-2010-07-299636","article-title":"Pathophysiology of sickle cell disease is mirrored by the red blood cell metabolome","volume":"117","author":"Darghouth","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2025.102909_bb0160","doi-asserted-by":"crossref","unstructured":"K. Sun, A. D'alessandro, M.H. Ahmed, Y. Zhang, A. Song, T.-P. Ko, T. Nemkov, J.A. Reisz, H. Wu, M. Adebiyi, Z. Peng, J. Gong, H. Liu, A. Huang, Y.E. Wen, A.Q. Wen, V. Berka, M. V Bogdanov, O. Abdulmalik, L. Han, A.-L. Tsai, M. Idowu, H.S. Juneja, R.E. Kellems, W. Dowhan, K.C. Hansen, M.K. Safo, Y. Xia, Structural and functional insight of sphingosine 1-phosphate-mediated pathogenic metabolic reprogramming in sickle cell disease, (n.d.). doi:https:\/\/doi.org\/10.1038\/s41598-017-13667-8.","DOI":"10.1038\/s41598-017-13667-8"},{"key":"10.1016\/j.bcmd.2025.102909_bb0165","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1182\/blood-2023-178709","article-title":"Deciphering metabolomic signatures associated with sickle cell disease using mouse models","volume":"142","author":"Montllor-Albalate","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2025.102909_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101630","article-title":"Metabolome changes during in vivo red cell aging reveal disruption of key metabolic pathways","volume":"23","author":"Jamshidi","year":"2020","journal-title":"IScience"},{"key":"10.1016\/j.bcmd.2025.102909_bb0175","doi-asserted-by":"crossref","unstructured":"Nathan DG, Oski FA, Miller DR, Gardner FH, Life-span and organ sequestration of the red cells in pyruvate kinase deficiency, N. Engl. J. Med. 278 (1968) 73\u201381. https:\/\/doi.org\/10.1056\/NEJM196801112780203?articleTools=true (accessed February 2, 2024).","DOI":"10.1056\/NEJM196801112780203"},{"key":"10.1016\/j.bcmd.2025.102909_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.735543","article-title":"Red blood cell metabolism in pyruvate kinase deficient patients","volume":"12","author":"Roy","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bcmd.2025.102909_bb0185","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a040550","article-title":"Nadph\u2014the forgotten reducing equivalent","volume":"13","author":"Chandel","year":"2021","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.bcmd.2025.102909_bb0190","series-title":"Inflammatory and Oxidative Stress Phenotypes in Transgenic Sickle Cell Mice","author":"Charrin","year":"2016"},{"key":"10.1016\/j.bcmd.2025.102909_bb0195","series-title":"Hemoglobin Oxidation-dependent Reactions Promote Interactions With Band 3 and Oxidative Changes in Sickle Cell-derived Microparticles","author":"Jana","year":"2018"},{"key":"10.1016\/j.bcmd.2025.102909_bb0200","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2141.1980.tb01186.x","article-title":"Superoxide dismutase, glutathione peroxidase, catalase and lipid peroxidation of normal and sickled erythrocytes","volume":"44","author":"Das","year":"1980","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2025.102909_bb0205","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1182\/blood-2007-04-081703","article-title":"Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease","volume":"111","author":"Morris","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2025.102909_bb0210","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1152\/ajpendo.00287.2005","article-title":"In vivo rates of erythrocyte glutathione synthesis in adults with sickle cell disease","volume":"291","author":"Reid","year":"2006","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bcmd.2025.102909_bb0215","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.freeradbiomed.2013.11.022","article-title":"Inborn defects in the antioxidant systems of human red blood cells","volume":"67","author":"Van Zwieten","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcmd.2025.102909_bb0220","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0009-8981(77)90143-7","article-title":"Influence of the redox state of glutathione upon pyruvate kinase in the intact erythrocyte","volume":"80","author":"Sprengers","year":"1977","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bcmd.2025.102909_bb0225","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1126\/science.1211485","article-title":"Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses","volume":"334","author":"Anastasiou","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.bcmd.2025.102909_bb0230","first-page":"2735","article-title":"EHA2024 Hybrid Congress (P1480): a novel allosteric activator of pyruvate kinase enhances human and mouse enzymatic activity and leads to hematological improvements in sickle cell disease mouse models","volume":"8","author":"Chen","year":"2024","journal-title":"Hemasphere"},{"key":"10.1016\/j.bcmd.2025.102909_bb0235","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/MOH.0000000000000134","article-title":"Human and murine erythropoiesis","volume":"22","author":"An","year":"2015","journal-title":"Curr. Opin. Hematol."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979625000014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979625000014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T19:51:02Z","timestamp":1741031462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979625000014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":47,"alternative-id":["S1079979625000014"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2025.102909","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Red blood cell pyruvate kinase properties in Townes and Berkeley sickle cell disease mouse models \u2013 Of mice and men","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2025.102909","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102909"}}